Sports Medicine Osiris Announces Initiation of a Phase III Trial for a New Investigational Drug, OTI-15-01, for the Treatment of Chronic Diabetic Foot Wounds byJosh SandbergOctober 8, 2015
Extremities Cartiva Announces Positive Final Data from its Cartiva SCI Pivotal Trial for Great Toe Arthritis byJosh SandbergJuly 17, 2015
Extremities Hospitals Anika Therapeutics Files Investigational Device Exemption to Initiate Phase III Study to Expand Indication of MONOVISC® to Treat Pain Caused by Osteoarthritis of the Hip byJosh SandbergJune 23, 2015
